quipazine has been researched along with mesulergine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 8 (57.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Anzini, M; Cagnotto, A; Cappelli, A; Emerit, BM; Giorgi, G; Hamon, M; Langer, T; Merahi, N; Skorupska, M; Vomero, S | 1 |
| Audia, JE; Baez, M; Cohen, ML; Kursar, JD; Lucaites, VL; Nelson, DL; Nissen, JS; Schenck, KW; Wainscott, DB | 1 |
| Anzini, M; Caccia, S; Cagnotto, A; Campiani, G; Cappelli, A; Consolo, S; Fracasso, C; Hamon, M; Mennini, T; Nacci, V; Uboldi, C; Vomero, S | 1 |
| Anzini, M; Bruni, G; Cappelli, A; De Benedetti, PG; Doucet, E; Hamon, M; Langer, T; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S | 1 |
| Anzini, M; Bruni, G; Canullo, L; Cappelli, A; De Benedetti, PG; Donati, A; Doucet, E; Giorgi, G; Hamon, M; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S | 1 |
| Butini, S; Caccia, S; Cagnotto, A; Campiani, G; Cervo, L; Dalla Valle, F; Fracasso, C; Gemma, S; Goegan, M; Greco, G; Hamon, M; Mennini, T; Morelli, E; Nacci, V; Novellino, E | 1 |
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
| Breeding, M; Sanders-Bush, E | 1 |
| Amedro, J; Brown, L; Smith, D; Williams, G | 1 |
| Carey, JE; Chen, C; Elliott, JM; Flanigan, TP; Kumar, C; McDonald, B; Newberry, NR; Newton, RA; Phipps, SL | 1 |
| Ebersole, BJ; Rosendorff, A; Sealfon, SC | 1 |
| Berg, KA; Clarke, WP; Cropper, JD; Emeson, RB; Niswender, CM; Sanders-Bush, E | 1 |
1 review(s) available for quipazine and mesulergine
| Article | Year |
|---|---|
Central serotonin receptors as targets for drug research.
Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin | 1987 |
13 other study(ies) available for quipazine and mesulergine
| Article | Year |
|---|---|
Novel, potent, and selective 5-HT3 receptor antagonists based on the arylpiperazine skeleton: synthesis, structure, biological activity, and comparative molecular field analysis studies.
Topics: Animals; Crystallography, X-Ray; Guinea Pigs; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Structure-Activity Relationship; Tumor Cells, Cultured | 1995 |
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
Topics: Animals; Binding Sites; Cell Line; Cloning, Molecular; Gastric Fundus; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth; Radioligand Assay; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Temperature | 1993 |
Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure.
Topics: Animals; Blood-Brain Barrier; Cell Line; Cerebral Cortex; Hybrid Cells; Magnetic Resonance Spectroscopy; Male; Mice; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Reflex; Serotonin Receptor Agonists; Spectrophotometry, Infrared; Structure-Activity Relationship | 1997 |
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
Topics: Animals; Benzene; Binding Sites; Glioma; Guanidine; Mice; Models, Molecular; Molecular Structure; Neuroblastoma; Phenanthridines; Piperazines; Quinolines; Quipazine; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
Topics: Animals; Binding, Competitive; Brain; Cell Line; Granisetron; In Vitro Techniques; Ligands; Male; Mice; Models, Molecular; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship | 1999 |
Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
Topics: Animals; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Brain; Guanidine; Guinea Pigs; Hybrid Cells; In Vitro Techniques; Ligands; Male; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship | 1999 |
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Antiparkinson Agents; Cells, Cultured; Choroid Plexus; DOM 2,5-Dimethoxy-4-Methylamphetamine; Epithelial Cells; Ergolines; Hallucinogens; Male; Phosphatidylinositols; Quipazine; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Stereoisomerism | 1991 |
A pharmacological analysis of the rat spinal cord serotonin (5-HT) autoreceptor.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Ergolines; Male; Piperazines; Potassium; Quipazine; Rats; Receptors, Serotonin; Serotonin; Spinal Cord; Spiperone; Tetrahydronaphthalenes; Tritium | 1988 |
Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Topics: Adrenergic alpha-Agonists; Amphetamines; Antiparkinson Agents; Calcium; Choroid Plexus; Electrophysiology; Ergolines; Ergotamine; Frontal Lobe; Hallucinogens; Humans; Hydrolysis; Ketanserin; Lysergic Acid Diethylamide; Mescaline; Methoxydimethyltryptamines; Neuroblastoma; Phosphatidylinositols; Piperazines; Quipazine; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Recombinant Proteins; RNA, Messenger; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium; Tumor Cells, Cultured | 1996 |
Conserved helix 7 tyrosine functions as an activation relay in the serotonin 5HT(2C) receptor.
Topics: Amino Acid Motifs; Amphetamines; Binding, Competitive; Cell Line; Conserved Sequence; Ergolines; Humans; Indoles; Inositol Phosphates; Ligands; Mianserin; Mutation; Protein Structure, Secondary; Pyridines; Quipazine; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection; Tyrosine | 2000 |
RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Topics: Amphetamines; Animals; Arachidonic Acid; Binding, Competitive; Bufotenin; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Ergolines; Inositol Phosphates; Lysergic Acid Diethylamide; Piperazines; Protein Isoforms; Quipazine; Radioligand Assay; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; RNA Editing; Serotonin; Serotonin Receptor Agonists; Tritium | 2001 |